Results 1 to 10 of about 54,490 (219)
Cryptococcus neoformans var. neoformans isolado do solo Cryptococcus neoformans var. neoformans isolated from soil [PDF]
Revista do Instituto de Medicina Tropical de São Paulo, 1993 Na tentativa de identificar a possível fonte de infecção, inquiriu-se, na história epidemiológica de 42 pacientes portadores de criptococose, o contato com pombos.
Clenise Canello Machado +2 more
doaj +6 more sources
A Peptide from Budding Yeast GAPDH Serves as a Promising Antifungal against Cryptococcus neoformans
Microbiology Spectrum, 2022 Infection of Cryptococcus neoformans is one of the leading causes of morbidity and mortality, particularly among immunocompromised patients. However, currently available drugs for the treatment of C. neoformans infection are minimal. Here, we report SP1,
Yang Zhang +12 more
doaj +1 more source
Pigment production on L-tryptophan medium by Cryptococcus gattii and Cryptococcus neoformans. [PDF]
PLoS ONE, 2014 In recent years strains previously grouped within Cryptococcus neoformans have been divided into two species C. neoformans and C. gattii, with Cryptococcus neoformans comprising serotypes A, D, and AD and C.
Stuart Chaskes +3 more
doaj +1 more source
Frontiers in Microbiology, 2021 The prevalent variants of Cryptococcus neoformans, and other Cryptococcus species in pigeon excreta in Western Region of Saudi Arabia were studied.
Bashir Sirag +6 more
doaj +1 more source
Case Reports in Infectious Diseases, 2021 Cryptococcus infection is caused by one of the two species, Cryptococcus neoformans, or the less common Cryptococcus gattii. While Cryptococcus neoformans commonly infects the immunocompromised population, Cryptococcus gattii has been seen more ...
Benjamin Billings +3 more
doaj +1 more source
Cryptococcus neoformans chitin synthase 3 plays a critical role in dampening host inflammatory responses [PDF]
, 2020 Cryptococcus neoformans is the most common disseminated fungal pathogen in AIDS patients, resulting in ∼200,000 deaths each year. There is a pressing need for new treatments for this infection, as current antifungal therapy is hampered by toxicity and/or
Hole, Camaron R +3 more
core +2 more sources
Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis. [PDF]
PLoS ONE, 2016 Cryptococcus neoformans is an opportunistic fungal pathogen and the causative agent of the disease cryptococcosis. Cryptococcosis is initiated as a pulmonary infection and in conditions of immune deficiency disseminates to the blood stream and central ...
Visesato Mor +8 more
doaj +1 more source
Les infections à Cryptococcus neoformans chez les patients infectés par le VIH : à propos de 27 cas
Revue Malienne d’Infectiologie et de Microbiologie, 2020 But du travail : Décrire les profils épidémiologiques, clinico-paracliniques, thérapeutiques et évolutifs des patients infectés par le VIH qui ont présenté une infection à Cryptococcus neoformans.
FN Etoughe +5 more
doaj +3 more sources
Cryptococcus neoformans endocarditis in an immunocompetentpatient a case report
BMC Cardiovascular Disorders, 2022 Background Cryptococcus neoformans is an invasive fungal infection commonly affecting immunocompromised patients as pneumonia or meningitis. More rarely, case reports describe Cryptococcus neoformans endocarditis, though nearly exclusively among patients
Colin N. McGuire, Dylan J. Walter
doaj +1 more source